S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money

PhaseBio Pharmaceuticals (PHAS) Insider Trading & Ownership

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.90%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$30,000.00
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$302,705.88
Get PHAS Insider Trade Alerts

Want to know when executives and insiders are buying or selling PhaseBio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PHAS Insider Buying and Selling by Quarter

PhaseBio Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/25/2022Enterprise Associates 13 L NewMajor ShareholderSell1,784,109$0.15$267,616.35  
5/23/2022Glen BurkhardtSVPSell11,248$0.79$8,885.92  
11/19/2021Glen BurkhardtVPSell5,766$2.37$13,665.42  
8/18/2021Clay ThorpDirectorBuy10,000$3.00$30,000.00  
5/20/2021Glen BurkhardtVPSell3,811$3.29$12,538.19  
(Data available from 1/1/2013 forward)

PHAS Insider Trading Activity - Frequently Asked Questions

Who is on PhaseBio Pharmaceuticals's Insider Roster?

The list of insiders at PhaseBio Pharmaceuticals includes Clay Thorp, Enterprise Associates 13 L New, and Glen Burkhardt. Learn more on insiders at PHAS.

What percentage of PhaseBio Pharmaceuticals stock is owned by insiders?

9.90% of PhaseBio Pharmaceuticals stock is owned by insiders. Learn more on PHAS's insider holdings.

Which PhaseBio Pharmaceuticals insiders have been selling company stock?

The following insiders have sold PHAS shares in the last 24 months: Enterprise Associates 13 L New ($267,616.35), and Glen Burkhardt ($8,885.92).

How much insider selling is happening at PhaseBio Pharmaceuticals?

Insiders have sold a total of 1,795,357 PhaseBio Pharmaceuticals shares in the last 24 months for a total of $276,502.27 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:PHAS) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners